Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
Evidence is accumulating that psychedelics may possess antidepressant activity, and this can potentially be explained through a multi-level (psychobiological, circuitry, (sub)cellular and molecular) analysis of the cognitive systems RDoC domain.
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approachhttps://pimaastricht.com/images/banners/igor1.jpg#joomlaImage://local-images/banners/igor1.jpg?width=1440&height=1080pimaastrichthttps://pimaastricht.com/templates/gk_bauhaus/images/logo.png
